About
Technology
Issues
FAQ
Links
Official Page
Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized Trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.